Bottom line
How much do RSPH and FTXH overlap?
23% of their top holdings overlap by weight. 7 securities appear in both funds' top 25, making up 12.7% of RSPH's assets and 27.1% of FTXH's. They are substantially different portfolios, so owning both adds real diversification.
Updated Nov 22, 2026
Overlap at a glance
Holdings RSPH and FTXH have in common
| Holding | % of RSPH | % of FTXH | Overlap |
|---|---|---|---|
| Regeneron Pharmaceuticals, Inc. | 1.96% | 2.72% | 1.96% |
| Charles River Laboratories International, Inc. | 1.93% | 1.49% | 1.49% |
| Bristol-Myers Squibb Co. | 1.82% | 6.29% | 1.82% |
| Amgen Inc. | 1.77% | 3.18% | 1.77% |
| Incyte Corp. | 1.76% | 2.39% | 1.76% |
| AbbVie Inc. | 1.73% | 7.39% | 1.73% |
| Viatris Inc. | 1.72% | 3.62% | 1.72% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in RSPH
- Bio-Techne Corp. — 2.13%
- IQVIA Holdings Inc. — 2.00%
- Baxter International Inc. — 1.99%
- Mettler-Toledo International Inc. — 1.94%
- Veeva Systems Inc. — 1.93%
- DaVita Inc. — 1.87%
- Moderna, Inc. — 1.85%
- Thermo Fisher Scientific Inc. — 1.84%
- Abbott Laboratories — 1.83%
- Universal Health Services, Inc. — 1.80%
- Labcorp Holdings Inc. — 1.78%
- Quest Diagnostics Inc. — 1.77%
- Becton, Dickinson and Co. — 1.73%
- DexCom, Inc. — 1.73%
- Revvity, Inc. — 1.72%
Only in FTXH
- Eli Lilly & Company — 7.77%
- Merck & Company Inc — 7.07%
- Johnson & Johnson — 6.96%
- Biogen Inc — 3.84%
- Cardinal Health Inc — 3.53%
- Vertex Pharmaceuticals Inc — 3.41%
- Pfizer Inc — 2.97%
- Gilead Sciences Inc — 2.89%
- United Therapeutics Corp — 2.72%
- Jazz Pharmaceuticals Plc — 2.49%
- Illumina Inc — 1.98%
- Zoetis Inc — 1.87%
- Exelixis Inc — 1.72%
- Medpace Holdings Inc — 1.41%
- Ptc Therapeutics Inc — 1.37%
Asset mix
| Asset type | RSPH | FTXH |
|---|---|---|
| Stocks | 99.9% | 99.9% |
| Cash & short-term funds | 2.3% | 0.1% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)
Country mix
| Country | RSPH | FTXH |
|---|---|---|
| US | 98.9% | 95.6% |
| IE | 3.4% | 3.8% |
| BM | — | 0.6% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)
Check another pair
FAQ
How much do RSPH and FTXH overlap?
What stocks do RSPH and FTXH have in common?
Should I own both RSPH and FTXH?
Which holds more stocks, RSPH or FTXH?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.